First Edition: December 5, 2016
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
35,281 - 35,300 of 112,564 Results
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Opinion writers contemplate what the Trump administration's pick to lead the Department of Health and Human Services portends in terms of health policy changes and offer cautions.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Outlets report on health news from Georgia, Massachusetts, Oregon, Maryland, Pennsylvania, Minnesota, California, Florida, Virginia and Missouri.
In other Medicaid news, some Minnesota residents on public health programs will have to switch to a new plan because an insurer and the state were unable to agree on a new contract. News outlets also report on developments the dire outlook for expansion in Virginia and how gunshot victims get help from the state-federal health insurance program.
New research shows that working memory -- the ability to retain a new piece of information even when our attention is temporarily directed elsewhere -- may not be as volatile as once thought. Also in public health news: labeling on homeopathic treatments, life in an Alzheimer's ward, a 'tidal wave' of hepatitis C, and more.
Other developments in the nation's drug crisis include $1 billion in federal funding to the states, the difficulties law enforcement faces in the fentanyl battle and the debate over family notifications of overdoses.
The state finalized the rule -- which requires aborted fetal remains be buried or cremated -- this week. Media outlets report on other news on abortion out of Arkansas, Ohio and Maryland.
Economist Mark Israel defended the Anthem-Cigna merger and said the Justice Department’s expert erred in ignoring savings from reduced medical costs estimated in his analysis of the deal's impact. Meanwhile, Anthem could face a $3 billion penalty from Blue Cross Blue Shield Association if it acquires Cigna and the Aetna-Humana trial is set to start on Monday.
Politico talks to former Democratic Senate Majority Leader Tom Daschle about what kind of HHS secretary Rep. Tom Price will turn out to be. Meanwhile, Price's stock portfolio includes investments in pharmaceutical, medical device, and health insurance companies, which could raise conflicts of interest questions.
It's unclear what any replacement proposals hold in store for pharmaceutical companies, but it seems like it might be a mixed bag. Meanwhile, some leaders in the industry think their colleagues' relief at a Trump administration instead of a Clinton administration is premature.
Bloomberg offers a look at the problems facing congressional Republicans, including the fact that even after six years of ardently trying to come up with a replacement plan there has yet to be one that the party has gotten behind. Meanwhile, amid fears of a mass exodus of insurers from the marketplace, Republicans have begun talks with the companies to figure out what can be done to keep them.
Meanwhile, House Speaker Paul Ryan dismisses Democrats' attacks over his vision for overhauling the program as "MediScare politics."
Today's early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Opinion writers explore issues related to public health and health care quality.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Outlets report on health news from Kansas, Florida, Michigan, Massachusetts, California and Georgia.
News outlets in Washington, Oregon and Illinois also report on other developments related to opioid use and abuse.
© 2026 KFF